4//SEC Filing
BAKER BIOTECH CAPITAL II GP LLC 4
Accession 0001181431-04-043787
CIK 0000911326other
Filed
Sep 13, 8:00 PM ET
Accepted
Sep 14, 9:15 PM ET
Size
16.3 KB
Accession
0001181431-04-043787
Insider Transaction Report
Form 4
TRIMERIS INCTRMS
BAKER BIOTECH CAPITAL II GP LLC
Director10% Owner
Transactions
- Purchase
Common Stock
2004-09-10$12.55/sh+33,484$420,348→ 1,689,680 total(indirect: See Footnote) - Purchase
Common Stock
2004-09-14$13.32/sh+22,322$297,329→ 1,731,311 total(indirect: See Footnote) - Purchase
Common Stock
2004-09-13$13.56/sh+17,859$242,152→ 1,708,989 total(indirect: See Footnote) - Purchase
Common Stock
2004-09-10$12.99/sh+1,450$18,837→ 1,691,130 total(indirect: See Footnote)
BAKER FELIX
Director10% Owner
Transactions
- Purchase
Common Stock
2004-09-10$12.99/sh+1,450$18,837→ 1,691,130 total(indirect: See Footnote) - Purchase
Common Stock
2004-09-13$13.56/sh+17,859$242,152→ 1,708,989 total(indirect: See Footnote) - Purchase
Common Stock
2004-09-14$13.32/sh+22,322$297,329→ 1,731,311 total(indirect: See Footnote) - Purchase
Common Stock
2004-09-10$12.55/sh+33,484$420,348→ 1,689,680 total(indirect: See Footnote)
BAKER JULIAN
Director10% Owner
Transactions
- Purchase
Common Stock
2004-09-10$12.55/sh+33,484$420,348→ 1,689,680 total(indirect: See Footnote) - Purchase
Common Stock
2004-09-13$13.56/sh+17,859$242,152→ 1,708,989 total(indirect: See Footnote) - Purchase
Common Stock
2004-09-14$13.32/sh+22,322$297,329→ 1,731,311 total(indirect: See Footnote) - Purchase
Common Stock
2004-09-10$12.99/sh+1,450$18,837→ 1,691,130 total(indirect: See Footnote)
Footnotes (10)
- [F1]In addition to Baker Biotech Capital II (GP), LLC, this Form 4 is being filed jointly by Julian C. Baker and Felix J. Baker, each of whom has the same business address as Baker Biotech Capital II (GP), LLC and may be deemed to have a pecuniary interest in securities owned by it. Felix J. Baker and Julian C. Baker are directors of the Issuer. Because of certain relationships with other security holders of the Issuer, the Reporting Persons are filing solely for informational purposes as if they were members of a group with such security holders. However, the Reporting Persons disclaim that they and any other person or persons in fact constitute a "group" for purposes of Section 13(d)(3) of the Securities Exchange Act of 1934, as amended, or Rule 13d-5 thereunder or that they are the beneficial owners of securities owned by such other persons, and each of them disclaims beneficial ownership of securities reported herein except to the extent of their pecuniary interest, if any, therein.
- [F10]Represents 1,144,755 shares of common stock owned directly by Baker Biotech Fund II, L.P., 502,454 shares of common stock owned directly by Baker Biotech Fund II (A), L.P., and 84,102 shares of common stock owned directly by Baker Biotech Fund II (Z), L.P
- [F2]Represents 29,435 shares of common stock purchased by Baker Biotech Fund II (A), L.P., and 4,049 shares of common stock purchased by Baker Biotech Fund II (Z), L.P.
- [F3]Represents 1,144,755 shares of common stock owned directly by Baker Biotech Fund II, L.P., 465,856 shares of common stock owned directly by Baker Biotech Fund II (A), L.P., and 79,069 shares of common stock owned directly by Baker Biotech Fund II (Z), L.P.
- [F4]Represents shares of common stock owned directly by Baker Biotech Fund II, L.P., shares of common stock owned directly by Baker Biotech Fund II (A), L.P., and shares of common stock owned directly by Baker Biotech Fund II (Z), L.P. Baker Biotech Fund II, L.P., Baker Biotech Fund II (A), L.P., and Baker Biotech Fund II (Z), L.P., are each limited partnerships of which the sole general partner is Baker Biotech Capital II, L.P., a limited partnership of which the sole general partner is Baker Biotech Capital II (GP), LLC. Felix J. Baker and Julian C. Baker are the controlling members of Baker Biotech Capital II (GP), LLC.
- [F5]Represents 1,275 shares of common stock purchased by Baker Biotech Fund II (A), L.P., and 175 shares of common stock purchased by Baker Biotech Fund II (Z), L.P.
- [F6]Represents 1,144,755 shares of common stock owned directly by Baker Biotech Fund II, L.P., 467,131 shares of common stock owned directly by Baker Biotech Fund II (A), L.P., and 79,244 shares of common stock owned directly by Baker Biotech Fund II (Z), L.P.
- [F7]Represents 15,700 shares of common stock purchased by Baker Biotech Fund II (A), L.P., and 2,159 shares of common stock purchased by Baker Biotech Fund II (Z), L.P.
- [F8]Represents 1,144,755 shares of common stock owned directly by Baker Biotech Fund II, L.P., 482,831 shares of common stock owned directly by Baker Biotech Fund II (A), L.P., and 81,403 shares of common stock owned directly by Baker Biotech Fund II (Z), L.P.
- [F9]Represents 19,623 shares of common stock purchased by Baker Biotech Fund II (A), L.P., and 2,699 shares of common stock purchased by Baker Biotech Fund II (Z), L.P.
Documents
Issuer
TRIMERIS INC
CIK 0000911326
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001244386
Filing Metadata
- Form type
- 4
- Filed
- Sep 13, 8:00 PM ET
- Accepted
- Sep 14, 9:15 PM ET
- Size
- 16.3 KB